Subscribe to Daily Review - your favourite M&A deals update.

Submit Deal

ORGANON & CO

Summary

Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia.

Deals Overview

Total Deals4

Valued Deals4

Total Value£ 7.18 B

Avg. Deal Size£ 1.80 B

Market Context

Parent Company

MERCK & CO

56 transactions

Senior Management

Kevin Ali
CEO
Matthew Walsh
CFO
Jennifer Halchak
Investors Relations Manager

Sort

jennifer halchak

Investors Relations Manager at ORGANON & CO

Manager

Deals

£ 1.79 B

Total Value

kevin ali

CEO at ORGANON & CO

Manager

Deals

£ 1.79 B

Total Value

matthew walsh

CFO at ORGANON & CO

Manager

Deals

£ 1.62 B

Total Value

felicia bisaro

Media Contact at ORGANON & CO

Manager

Deal

£ 910 M

Total Value

karissa peer

Communications Director at ORGANON & CO

Manager

Deals

£ 881 M

Total Value

edward barger

Investors Relations Manager at ORGANON & CO

Manager

Deals

£ 881 M

Total Value

Explore dealmakers beyond your search with a free MergerLinks account.

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy